Overview
About HAC Pharma
H.A.C. Pharma is a French independent pharmaceutical “Exploitant” company.
Since 2007, H.A.C. Pharma is delivering mature and innovative high value drugs to patients through distribution, in-licensing and acquisition deals.
H.A.C. Pharma has unique end-to-end capabilities to market high therapeutic value drugs on the French market, especially in pathologies with reduced alternatives for the patient.
H.A.C. Pharma is a partner of choice to integrate your products at any step of their lifecycle: from regulatory and market access strategy, to product importation and distribution, including marketing and sales strategy, when required.
The company's drugs are promoted in France, with its own sales force, to specialists in hospital and retail channels in the area of endocrinology, neurology, gynecology, onco-hematology and gastroenterology.
H.A.C. Pharma also works with a network of trusted distributors in 6 European countries (Spain, Italy, Belgium, Austria, Switzerland and Portugal).
Since 2007, H.A.C. Pharma is delivering mature and innovative high value drugs to patients through distribution, in-licensing and acquisition deals.
H.A.C. Pharma has unique end-to-end capabilities to market high therapeutic value drugs on the French market, especially in pathologies with reduced alternatives for the patient.
H.A.C. Pharma is a partner of choice to integrate your products at any step of their lifecycle: from regulatory and market access strategy, to product importation and distribution, including marketing and sales strategy, when required.
The company's drugs are promoted in France, with its own sales force, to specialists in hospital and retail channels in the area of endocrinology, neurology, gynecology, onco-hematology and gastroenterology.
H.A.C. Pharma also works with a network of trusted distributors in 6 European countries (Spain, Italy, Belgium, Austria, Switzerland and Portugal).